Pathnsitu Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 8.00 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.99 Cr
- Revenue Growth 3.50%
- Profit Growth 14.29%
- Ebitda 9.03%
- Net Worth 30.80%
- Total Assets 16.88%
About Pathnsitu Biotechnologies
Pathnsitu Biotechnologies Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 September 2013 and has a history of 11 years and four months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹9.99 Cr.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U36935TG2013PTC089905
-
Company No.
089905
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Sep 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Pathnsitu Biotechnologies Private Limited offer?
Pathnsitu Biotechnologies Private Limited offers a wide range of products and services, including Medical Consultancy Services, Custom Antibody Services.
Who are the key members and board of directors at Pathnsitu Biotechnologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhanam Doss
|
Director | 01-Apr-2014 | Current |
|
Kamal Peddinti
|
Director | 06-Sep-2013 | Current |
|
Upendra Dubey
|
Director | 06-Sep-2013 | Current |
Financial Performance of Pathnsitu Biotechnologies.
Pathnsitu Biotechnologies Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.5% increase. The company also saw a substantial improvement in profitability, with a 14.29% increase in profit. The company's net worth Soared by an impressive increase of 30.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pathnsitu Biotechnologies?
In 2021, Pathnsitu Biotechnologies had a promoter holding of 58.00% and a public holding of 42.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medtotes Private LimitedSanthanam Doss, Kamal Peddinti and 1 more are mutual person
-
Vivin Biotech Private LimitedSanthanam Doss and Kamal Peddinti are mutual person
Charges (Loans)
₹99.91 M
₹0
Charges Breakdown by Lending Institutions
- Others : 7.53 Cr
- Axis Bank Limited : 2.25 Cr
- Hdfc Bank Limited : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2024 | Others | ₹4.03 Cr | Open |
| 26 Dec 2023 | Others | ₹2.00 Cr | Open |
| 18 Dec 2023 | Hdfc Bank Limited | ₹2.11 M | Open |
| 07 Jan 2022 | Axis Bank Limited | ₹2.50 M | Open |
| 03 Jan 2020 | Axis Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Pathnsitu Biotechnologies?
Pathnsitu Biotechnologies has a workforce of 101 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pathnsitu Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pathnsitu Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.